Skip to search formSkip to main contentSkip to account menu

CA 19-9 measurement

Known as: CA 19-9 assay, CA-19-9 Measurement, Cancer Antigen 19-9 Measurement 
A test that measures the level of CA 19-9 in the blood. CA 19-9 is a tumor marker released into the bloodstream from both cancer cells and normal… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
assays have emerged as important prognostic factors in pancreatic cancer (PC). Our recent research confirmed that not only DD… 
2007
2007
症例は76歳男性.主訴は腹部腫瘤.現病歴は平成12年11月,左側腹部の腫瘤を触知し,腹部US上膵体部に約9cmの嚢胞性病変を認め,当科紹介入院.入院時現症は,身長168cm,体重54kg… 
2007
2007
術前に血中CA19-9が16,000U/mlと異常高値を示したCA19-9産生胃癌の1例を報告する. 症例は68歳, 男性. 検診の上部消化管造影にて異常を指摘され, 当院を受診した. 上部消化管内視鏡検査にて幽門部に2… 
1998
1998
AIM:To assess the diagnostic values of tumor markers for pancreatic cancer.METHODS:Pancreatic cancer-associated antigen from… 
1995
1995
Monoclonal antibodies (mabs) have considerable potential for specific cancer treatment. However, due to the antigen heterogeneity… 
1993
1993
UNLABELLED The aims of this study were to (1) evaluate the diagnostic utility of a new tumor marker, TPS, with respect to TPA and… 
1988
1988
The diagnostic role of serum and pancreatic juice CA 19-9 determination in discriminating surgically resectable pancreatic cancer… 
1987
1987
症例. 64才,女性.心窩部痛のため来院.アミラーゼ, CEA, CA19-9の高値を認めたため精査入院. ERCP… 
1986
1986
Levels of a new carbohydrate antigen CA 19-9, which is a monosialoganglioside identified by a monoclonal antibody raised against…